The law bans clawbacks, mail-order rebates, spread pricing, patient steering and networks solely composed of affiliate pharmacies, according to a news release. It also aims to block data-sharing without patients’ consent.
On the “Big Pharma” side, the legislation requires drugmakers to report price increases surpassing 15 percent after one year and cumulative list price increasing 30 percent or more within three years.
At the federal level, about half a dozen bills looking to regulate the PBM industry are wading through committees.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
